Gf Fund Management Co. Ltd. Tarsus Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 803 shares of TARS stock, worth $38,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
803Holding current value
$38,415% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$156 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$155 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$121 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$120 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$108 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.28B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...